Aapro, Matti
Article History
Received: 17 December 2017
Accepted: 24 January 2018
First Online: 19 March 2018
Compliance with ethical standards
:
: Dr. Aapro has disclosed that he has received consulting fees or honoraria from Amgen. He has also received payment for lectures and/or support for travel fromAmgen, Helsinn, Hospira, Johnson & Johnson, Novartis, Pierre Fabre Medicament, Roche, Sandoz, TESARO, Teva, and Vifor Pharma. Dr. Aapro has received research funding from Helsinn, Hospira, Novartis, Pierre Fabre Medicament, and Sandoz. He has also disclosed receiving fees for participation in advisoryor review activities from Helsinn Healthcare, Hospira, Merck, Merck KGaA, Pierre Fabre Medicament, Sandoz, TESARO, Teva, and ViforPharma.